The Quantum Blue® Anti-Infliximab test is a semi-quantitative lateral flow test for the determination of the presence of anti-infliximab antibodies in human serum samples. Quantum Blue® Anti-Infliximab is combined with the Quantum Blue® Reader for measurement of the results.
Quantum Blue® Anti-Infliximab
BÜHLMANN Quantum Blue® Anti-Infliximab is for Research Use Only in the US. Not for use in diagnostics procedures in the US.
BÜHLMANN Quantum Blue® Anti-Infliximab, Health Canada Licence: 105476
Anti-Infliximab Antibodies
The BÜHLMANN Quantum Blue® Anti-Infliximab is the fastest assay for anti-infliximab antibody measurements in the market and is designed for the selective measurement of these antibodies by a sandwich immunoassay.
Quantum Blue®Anti-Infliximab Product information